Vis enkel innførsel

dc.contributor.authorBesada, Emilio
dc.contributor.authorNossent, Johannes C
dc.date.accessioned2014-09-10T10:58:27Z
dc.date.available2014-09-10T10:58:27Z
dc.date.issued2012
dc.description.abstractCRP is a marker of inflammation and is also a known cardiovascular risk factor. Patients with systemic lupus erythematosus (SLE) have moderately elevated CRP levels and develop organ damage , that includes an increased rate of cardiovascular events.en
dc.identifier.citationScandinavian Journal of Rheumatology 41(2012) s. 60-61en
dc.identifier.cristinIDFRIDAID 1023085
dc.identifier.issn0300-9742
dc.identifier.urihttps://hdl.handle.net/10037/6644
dc.identifier.urnURN:NBN:no-uit_munin_6244
dc.language.isoengen
dc.publisherInforma Healthcareen
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759en
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759en
dc.titleCRP as a marker for myocardial infarction and for damage accrual in systemic lupus erythematosus patients: results from a single-centre longitudinal studyen
dc.typeJournal articleen
dc.typeTidsskriftartikkelen
dc.typePeer revieweden


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel